Company Filing History:
Years Active: 1979
Title: Albrecht Fleckenstein: Innovator in Cardio-Protective Pharmaceuticals
Introduction
Albrecht Fleckenstein is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in developing cardio-protective compositions. His work has implications for improving heart health and managing cardiovascular conditions.
Latest Patents
Fleckenstein holds a patent for a cardio-protective pharmaceutical composition. This composition includes an inert carrier and a pharmaceutically-effective amount of a combination of 2,4,7-triamino-6-phenyl-pteridine (triamterene) and a calcium antagonist, such as α-isopropyl-α-[(N-methyl-N-homoveratryl)-γ-aminopropyl]-3,4-dimethoxyphenyl-acetonitrile-hydrochloride (verapamil). This innovative formulation aims to enhance cardiovascular protection.
Career Highlights
Albrecht Fleckenstein has been associated with Rohm Pharma GmbH, where he has contributed to various research and development projects. His expertise in pharmaceuticals has positioned him as a key figure in the industry.
Collaborations
Fleckenstein has worked alongside notable colleagues, including Johanna Janke and Klaus Lossnitzer. Their collaborative efforts have further advanced the research in cardio-protective therapies.
Conclusion
Albrecht Fleckenstein's contributions to the field of pharmaceuticals, particularly in cardio-protective compositions, highlight his innovative spirit and dedication to improving heart health. His work continues to influence the pharmaceutical landscape.